A 52-year-old woman presents with a 3-week history of rapid-onset swelling, erythema, and a peau d'orange appearance of her right breast. Examination reveals diffuse induration, warmth, and enlargement of the right breast, along with palpable right axillary lymphadenopathy. Suspecting inflammatory breast cancer, arrange the following steps in the standard diagnostic and therapeutic sequence for this patient, from the initial step to the final step.
- 1Core needle biopsy of the breast and skin punch biopsy
- 2Systemic neoadjuvant chemotherapy
- 3Modified radical mastectomy
- 4Post-mastectomy radiation therapy
Answer
The correct sequence for managing inflammatory breast cancer is to first obtain histologic diagnosis via biopsies, followed by systemic neoadjuvant chemotherapy, then surgical resection via modified radical mastectomy, and finally post-mastectomy radiation therapy.
The correct ordering reflects the established multidisciplinary approach to inflammatory breast cancer (IBC). IBC is an aggressive, locally advanced malignancy (Stage III) at the time of diagnosis. After establishing the diagnosis with a core needle and skin punch biopsy, the standard of care dictates upfront systemic neoadjuvant chemotherapy. This is crucial to reduce the tumor burden and treat potential micrometastases. Once the tumor has responded, local control is achieved with a modified radical mastectomy (breast-conserving surgery is not an option due to the diffuse nature of the disease). Finally, post-mastectomy radiation therapy is administered to further consolidate local control.
Step-by-Step Solution
Key Concept
The standard sequence of management for inflammatory breast cancer is tissue diagnosis, followed by neoadjuvant chemotherapy, modified radical mastectomy, and adjuvant post-mastectomy radiation therapy.
Estimated Time:1m 0s